← Back to Search

Expressive Writing Therapy for Cancer Survivors

N/A

Recruiting

Research Sponsored by New York University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 1-month follow-up, 3-month follow-up, and 6-month follow-up

Awards & highlights

Study Summary

This trial is testing a new intervention to help Chinese American cancer survivors. The intervention is called Expressive Helping (EH). The trial will test if this intervention is feasible and effective.

Who is the study for?

This trial is for Chinese American cancer survivors over 18 who prefer Mandarin or Cantonese and can read/write in Chinese. They should be within 5 years of completing treatment for stage I-III cancer. Those with writing difficulties or active in support groups more than once a week cannot join.Check my eligibility

What is being tested?

The study tests the Expressive Helping (EH) intervention's feasibility and effectiveness compared to Expressive Writing and Factual Writing among participants, randomly assigning them to one of these activities.See study design

What are the potential side effects?

Since this trial involves writing interventions rather than medical treatments, traditional side effects are not applicable. Participants may experience emotional discomfort while reflecting on their cancer experiences.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 1-month follow-up, 3-month follow-up, and 6-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 1-month follow-up, 3-month follow-up, and 6-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 1-month follow-up, 3-month follow-up, and 6-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Completion rate of writing sessions

Recruitment rates

Retention rates

Secondary outcome measures

Anxiety

Changes in cancer-related fatigue assessed by the Functional Assessment of Chronic Illness Therapy - Fatigue

Changes in depressive symptoms assessed by the Center for Epidemiologic Studies Depression Scale

+2 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Expressive HelpingExperimental Treatment1 Intervention

Participants complete a 20-minute expressive writing session once per week for the first three weeks. During Week 4, participants complete a 20-minute peer support writing session.

Group II: Expressive WritingActive Control1 Intervention

Participants complete a 20-minute expressive writing session once per week for four weeks.

Group III: Factual WritingActive Control1 Intervention

Participants complete a 20-minute factual writing about their cancer diagnosis and treatment every week for four weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Expressive Helping

2022

Completed Phase 3

~710

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

New York UniversityLead Sponsor

226 Previous Clinical Trials

314,009 Total Patients Enrolled

National Institute on Minority Health and Health Disparities (NIMHD)NIH

383 Previous Clinical Trials

1,216,251 Total Patients Enrolled

Media Library

Expressive Helping Clinical Trial Eligibility Overview. Trial Name: NCT05456100 — N/A

Cancer Research Study Groups: Expressive Helping, Expressive Writing, Factual Writing

Cancer Clinical Trial 2023: Expressive Helping Highlights & Side Effects. Trial Name: NCT05456100 — N/A

Expressive Helping 2023 Treatment Timeline for Medical Study. Trial Name: NCT05456100 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities to enroll in the trial at this time?

"As per clinicaltrials.gov, this study is actively enrolling suitable participants. It was inaugurated on July 14th 2022 and the last update was made on October 31st 2022."

Answered by AI

Could individuals over the age of forty-five participate in this medical experiment?

"The parameters for enrollment in this medical trial are between 18 and 80 years of age. Young people below 18 can look into 62 other trials, while those over 65 may select from a pool of 431 options."

Answered by AI

What is the total enrolment size for this clinical trial?

"Affirmative. According to data available on clinicaltrials.gov, this research project which was initially posted in the middle of July 2022 is now recruiting participants. 108 volunteers are sought from 1 medical centre for participation in the trial with its most recent update being at the end of October 2022."

Answered by AI

Who is eligible to enroll in this research endeavor?

"Eligible candidates for this medical trial must have a malignancy and be aged between 18 to 80. Enrollment is expected to include 108 people in total."

Answered by AI

What is the chief aim of this medical research endeavor?

"The primary outcome of this 6 month trial will be the completion rate during writing sessions. Secondary objectives include a measure of depressive symptoms using the CES-D scale (0 - 30, higher is worse), perceived stress with PSS (0 - 40, higher is worse) and health related quality of life via FACT-G score range 0 to 108)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Chinese American Cancer Survivors Writing Study

William Tsai 2022. "Chinese American Cancer Survivors Writing Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05456100.